These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 11409797

  • 21. [Interest of sentinel lymph node biopsy for the staging of ductal carcinoma in situ].
    Buttarelli M, Houvenaeghel G, Martino M, Rossi I, Ronda I, Ternier F, Tallet A, Jacquemier J.
    Ann Chir; 2004 Nov; 129(9):508-12. PubMed ID: 15556580
    [Abstract] [Full Text] [Related]

  • 22. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E.
    Cancer; 2006 Oct 15; 107(8):1760-8. PubMed ID: 16977650
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
    Leidenius M, Salmenkivi K, von Smitten K, Heikkilä P.
    J Surg Oncol; 2006 Oct 01; 94(5):380-4. PubMed ID: 16967467
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
    Porembka MR, Abraham RL, Sefko JA, Deshpande AD, Jeffe DB, Margenthaler JA.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2709-19. PubMed ID: 18483831
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer].
    Takács T, Szentpáli K, Paszt A, Ormándi K, Lázár M, Pálka I, Kahán Z, Lázár G.
    Magy Onkol; 2006 Oct 01; 50(3):247-51. PubMed ID: 17099786
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.
    Guth AA, Mercado C, Roses DF, Darvishian F, Singh B, Cangiarella JF.
    Breast J; 2008 Oct 01; 14(4):335-9. PubMed ID: 18537917
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF.
    Cancer; 2003 Nov 15; 98(10):2105-13. PubMed ID: 14601079
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
    van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K.
    Eur J Surg Oncol; 2008 Jun 15; 34(6):631-5. PubMed ID: 17851019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.